You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: Complete response of Sweet syndrome associated with myelodysplastic syndrome to 5-azacytidine

€3.03

SKU: product-article-40276 Category: General

Description
Reviews (0)

Description

Complete response of Sweet syndrome associated with myelodysplastic syndrome to 5-azacytidine

Reviews

There are no reviews yet.

Be the first to review “Article: Complete response of Sweet syndrome associated with myelodysplastic syndrome to 5-azacytidine”

You must be logged in to post a review.

Top

Article: Complete response of Sweet syndrome associated with myelodysplastic syndrome to 5-azacytidine

Description

Reviews

Related products

Article: Highlights in genitourinary cancers

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in digestive oncology